Health / Medical Topics

    hLL1

    A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. hLL1 is a type of monoclonal antibody. Also called IMMU-110 and milatuzumab. (NCI Dictionary)




    YOU MAY ALSO LIKE

    In transcription regulators of cell cycle control, cell determination, and cell differentiation, the conserved HLH (Helix-Loop-Helix) Domain of 40-50 amino acids forms…
    A rare disorder in which histiocytes and lymphocytes (types of white blood cells) build up in organs including the skin, spleen, and…
    Human HLF wild-type allele is located in the vicinity of 17q22 and is approximately 60 kb in length. This allele, which encodes…
    This gene is involved in both transcriptional regulation and DNA binding.
    A preparation of allogeneic HLA-matched leukocytes treated with a derivative of placental protein 14 (PP14) with potential immunomodulating activity. PP14 derivative-treated HLA-matched…
    Human HLA-G wild-type allele is located in the vicinity 6p21.3 and is approximately 4 kb in length. This allele, which encodes HLA…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact